Prognostic factors and survival study in high-grade glioma in the elderly

References

• DeAngelis LM. Brain tumors. N Engl J Med 2001;344:114–23.
   PubMed Web of Science ®Google Scholar
• Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncol 2012;14:v1–49.
   PubMed Web of Science ®Google Scholar
• Donato V, Papaleo A, Castrichino A, et al. Prognostic implication of clinical and pathologic features in patients with glioblastoma multiforme treated with concomitant radiation plus temozolomide. Tumori 2007;93:248–56.
   PubMed Web of Science ®Google Scholar
• Tanaka S, Meyer FB, Buckner JC, Uhm JH, Yan ES, Parney IF. Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients. J Neurosurg 2012;118:786-98.
   PubMed Web of Science ®Google Scholar
• Raysi DS, De PD, Marzi S, et al. Survival prognostic factors in patients with glioblastoma: our experience. J Neurosurg Sci 2012;56:239–45.
   PubMed Web of Science ®Google Scholar
• Chaichana KL, Halthore AN, Parker SL, et al. Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection. Clinical article. J Neurosurg 2011;114:604–12.
   PubMed Web of Science ®Google Scholar
• Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery 2008;62:753–64.
   PubMed Web of Science ®Google Scholar
• Chang SM, Parney IF, Huang W, et al. Patterns of care for adults with newly diagnosed malignant glioma. JAMA 2005;293:557–64.
   PubMed Web of Science ®Google Scholar
• McGirt MJ, Chaichana KL, Gathinji M, et al. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg 2009;110:156–62.
   PubMed Web of Science ®Google Scholar
• Chakrabarti I, Cockburn M, Cozen W, Wang YP, Preston-Martin S. A population-based description of glioblastoma multiforme in Los Angeles County, 1974–1999. Cancer 2005;104:2798–806.
   PubMed Web of Science ®Google Scholar
• Fleury A, Menegoz F, Grosclaude P, et al. Descriptive epidemiology of cerebral gliomas in France. Cancer 1997;79:1195–202.
   PubMed Web of Science ®Google Scholar
• Bauman GS, Gaspar LE, Fisher BJ, Halperin EC, Macdonald DR, Cairncross JG. A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1994;29:835–9.
   PubMed Web of Science ®Google Scholar
• Laigle-Donadey F, Delattre JY. Glioma in the elderly. Curr Opin Oncol 2006;18:644–7.
   PubMed Web of Science ®Google Scholar
• Marijnen CA, van den Berg SM, van Duinen SG, Voormolen JH, Noordijk EM. Radiotherapy is effective in patients with glioblastoma multiforme with a limited prognosis and in patients above 70 years of age: a retrospective single institution analysis. Radiother Oncol 2005;75:210–6.
   PubMed Web of Science ®Google Scholar
• Floyd SR, Kasper EM, Uhlmann EJ, Fonkem E, Wong ET, Mahadevan A. Hypofractionated Radiotherapy and stereotactic boost with concurrent and adjuvant temozolamide for glioblastoma in good performance status elderly patients – early results of a phase II trial. Front Oncol 2012;2:122.
   PubMedGoogle Scholar
• Mangiola A, Maira G, De BP, et al. Glioblastoma multiforme in the elderly: a therapeutic challenge. J Neurooncol 2006;76:159–63.
   PubMed Web of Science ®Google Scholar
• Wen PY, Macdonald DR, Reardon DA, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 2010;28:1963–72.
   PubMed Web of Science ®Google Scholar
• Cabrini G, Fabbri E, Lo NC, Dechecchi MC, Gambari R. Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review). Int J Oncol 2015;47:417-28.
   PubMed Web of Science ®Google Scholar
• Zarnett OJ, Sahgal A, Gosio J, et al. Treatment of elderly patients with glioblastoma: a systematic evidence-based analysis. JAMA Neurol 2015;72:589–96.
   PubMed Web of Science ®Google Scholar
• Kaplan RS. Supratentorial malignant gliomas: risk patterns and therapy. J Natl Cancer Inst 1993;85:690–1.
   PubMedGoogle Scholar
• Villa S, Vinolas N, Verger E, et al. Efficacy of radiotherapy for malignant gliomas in elderly patients. Int J Radiat Oncol Biol Phys 1998;42:977–80.
   PubMed Web of Science ®Google Scholar
• Instituto Nacional de Estadística. Spanish National Institute of Statistics. 2012. Ref Type: Electronic Citation.
   Google Scholar
• Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000;343:1350–4.
   PubMed Web of Science ®Google Scholar
• Jeremic B, Shibamoto Y, Grujicic D, et al. Short-course radiotherapy in elderly and frail patients with glioblastoma multiforme. A phase II study. J Neurooncol 1999;44:85–90.
   PubMed Web of Science ®Google Scholar
• Marina O, Suh JH, Reddy CA, et al. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article. J Neurosurg 2011;115:220–9.
   PubMed Web of Science ®Google Scholar
• Mohan DS, Suh JH, Phan JL, Kupelian PA, Cohen BH, Barnett GH. Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Int J Radiat Oncol Biol Phys 1998;42:981–7.
   PubMed Web of Science ®Google Scholar
• Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987–96.
   PubMed Web of Science ®Google Scholar
• Wick W, Platten M, Meisner C, et al. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol 2012;13:707–15.
   PubMed Web of Science ®Google Scholar
• Wiestler B, Claus R, Hartlieb SA, et al. Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective. Neuro-oncology 2013;15:1017–26.
   PubMed Web of Science ®Google Scholar